MAOB and Parkinson disease: Elderly patients initiated PD treatment with levodopa monotherapy, and a second therapy such as MAO-B inhibitors, non-ergot DAs, or zonisamide was added to levodopa when the levodopa dose increased to 300 mg, similar to younger patients.